Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

AUST vs AKAN: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

AUST Captures Overall Composite Edge (39.4 SELL vs 39.8 SELL), While AKAN Leads 3–2 on Growth & Valuation Pillars

AUST Overall Winner 6-Pillar Tally: AUST 2 – 3 AKAN (1 Tie) Matrix Metrics: AUST 3 – 3 AKAN

As of Nov 20, 2026, Austin Gold Corp. (AUST) captures the overall head-to-head institutional edge over Akanda Corp. Common Shares (AKAN) on higher Unified Composite conviction (39.4/100 SELL vs. 39.8/100 SELL) after splitting the core matrix 3–3 (led by Profitability & Quality, Options & Positioning), while AKAN wins 3–2 across the 6-pillar growth and valuation breakdown. AUST trades at $0.53 (N/M Forward P/E, 0.0% operating margin) versus AKAN at $4.23 (N/M Forward P/E, -1254.5% operating margin).

  • Growth vs. Quality Trade-Off: AUST earns the overall head-to-head edge with a stronger Unified Composite Score (39.4/100 SELL vs. AKAN 39.8/100 SELL) and 1.91β · 77% Vol risk profile, whereas AKAN leads top-line expansion (+21.9% YoY revenue growth, N/M PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates.
  • Defensive Composite Rating Caution: Although AUST compares more favorably head-to-head, both AUST (39.4/100 SELL) and AKAN (39.8/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
  • Technical & Structure Timing Caution: AUST is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 23.3); meanwhile AKAN is in a Breakdown options structure phase (RSI 75.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About AUST vs AKAN
AUST NYSE American Head-to-Head Winner
Austin Gold Corp.
Gold And Silver Ores
$0.53
-8.58% 1D
Market Cap $7.9M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 1.91β · 77% Vol
Unified Composite Score
39.4 / 100 SELL
Tech 25.0 Fund 43.0 Flow 50.0 Mom 59.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -18.7%), weak momentum, RSI 23
RSI-14: 23.3 · SMA20: $0.73 · SMA50: $0.88
AKAN NASDAQ
Akanda Corp. Common Shares
Medicinal Chemicals & Botanical Products
$4.23
+23.32% 1D
Market Cap $12.2M
TTM Revenue $662,469
Forward P/E N/M
Beta / 30D Vol 4.82β · 524% Vol
Unified Composite Score
39.8 / 100 SELL
Tech 15.0 Fund 36.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 75
RSI-14: 75.2 · SMA20: $1.52 · SMA50: $1.88

6-Pillar Scorecard Institutional Category Breakdown (AUST 2 – 3 AKAN)

Columns: Metric · AUST · AKAN
1. Valuation Multiples AKAN
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M 18.5x
2. Growth & Scale AKAN
Revenue Growth (YoY) +0.0% +21.9%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) N/A $662,469
Market Cap $7.9M $12.2M
3. Profitability & Quality AUST
Gross Margin N/A -12.0%
Operating Margin 0.0% -1254.5%
Net Profit Margin 0.0% 0.0%
Return on Equity (ROE) -33.7% -60.9%
4. Balance Sheet & Cash Flow AKAN
Cash Generation (TTM) -$2.7M -$7.9M EBITDA
Cash Flow Margin N/A N/A
Net Cash / Leverage $0.46 Book/Sh · -33.7% ROE -60.9% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning AUST
Options Structure Phase UNCLASSIFIED BREAKDOWN
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown ACCUMULATION · Neutral
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Gold Operator Drug Manufacturers - Specialty & Generic Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: AUST (3) vs AKAN (3)
Institutional Metric AUST AKAN Criterion Row Edge
Market Capitalization
Scale
$7.9M $12.2M Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+0.0% +21.9% Higher Growth AKAN
Operating Margin (TTM)
Profitability
0.0% -1254.5% Higher Margin AUST
Net Profit Margin
Profitability
0.0% 0.0% Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
-33.7% -60.9% Higher ROE AUST
52-Week Range Position
Momentum
0% ($1–$4) 5% ($0–$79) Stronger Trend AKAN
Beta / 30D Volatility
Risk Regime
1.91β · 77% Vol 4.82β · 524% Vol Lower Realized Risk AUST
Unified Institutional Score
Composite Signal
39.4 / 100 (SELL) 39.8 / 100 (SELL) Higher Composite AKAN
Trailing 12M Revenue (USD)
Operating Scale
N/A $662,469 FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A -12.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · 18.5x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$2.7M ($0.46 Book/Sh · -33.7% ROE) -$7.9M EBITDA (-60.9% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon AKAN +301.64 pp
AUST: -33.81% · AKAN: +267.83%
3M Horizon AKAN +74.28 pp
AUST: -60.11% · AKAN: +14.17%
6M Horizon AUST +25.22 pp
AUST: -59.18% · AKAN: -84.4%
1Y Horizon AKAN +425.58 pp
AUST: -67.29% · AKAN: +358.29%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AUST vs AKAN. Trailing 12-month operating profitability (AUST 0.0% vs AKAN -1254.5%) and valuation multiples (AUST N/M vs AKAN N/M Forward P/E) are benchmarked directly in Pillar 4 below.

AUST ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. Margin0.0%
ROE / Fwd P/E-33.7% · N/M
AKAN ADR TTM Benchmark FX-Normalized USD
TTM Revenue$662,469
Gross Margin-12.0%
Op. Margin-1254.5%
ROE / Fwd P/E-60.9% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
AUST UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact AUST Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
AKAN BREAKDOWN
140d in phase · OBV ACCUMULATION
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow ACCUMULATION
Exact AKAN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
AUST Moat Profile Cyclical / Execution-Driven Positioning
Gold Operator
Competes within the Gold value chain with $7.9M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
AKAN Moat Profile Cyclical / Execution-Driven Positioning
Drug Manufacturers - Specialty & Generic Operator
Competes within the Drug Manufacturers - Specialty & Generic value chain with $12.2M market capitalization and -1254.5% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ AUST vs AKAN Key Questions & Quantitative Answers

As of Nov 20, 2026, Austin Gold Corp. (AUST) captures the overall head-to-head institutional edge over Akanda Corp. Common Shares (AKAN) on higher Unified Composite conviction (39.4/100 SELL vs. 39.8/100 SELL) after splitting the core matrix 3–3 (led by Profitability & Quality, Options & Positioning), while AKAN wins 3–2 across the 6-pillar growth and valuation breakdown. AUST trades at $0.53 (N/M Forward P/E, 0.0% operating margin) versus AKAN at $4.23 (N/M Forward P/E, -1254.5% operating margin). Growth vs. Quality Trade-Off: AUST earns the overall head-to-head edge with a stronger Unified Composite Score (39.4/100 SELL vs. AKAN 39.8/100 SELL) and 1.91β · 77% Vol risk profile, whereas AKAN leads top-line expansion (+21.9% YoY revenue growth, N/M PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates. Defensive Composite Rating Caution: Although AUST compares more favorably head-to-head, both AUST (39.4/100 SELL) and AKAN (39.8/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: AUST is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 23.3); meanwhile AKAN is in a Breakdown options structure phase (RSI 75.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

AKAN leads the Growth & Scale pillar: AUST posts +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin), compared with AKAN at +21.9% YoY revenue growth and +0.0% YoY earnings growth on $662,469 TTM revenue (-12.0% gross margin, -1254.5% operating margin). On trailing 12-month operating scale, AUST generates N/A in USD-normalized revenue versus $662,469 for AKAN. In operating R&D and SG&A reinvestment, AUST deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for AKAN.

AKAN screens cheaper on headline valuation multiples. AUST trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported FCF margin), whereas AKAN trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 18.5x EV/Revenue (unreported EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AUST (-33.7% ROE) versus AKAN (-60.9% ROE) capital efficiency.

In options market volatility and institutional positioning, AUST carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.91β · 77% Vol realized risk). By comparison, AKAN carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (4.82β · 524% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.